November 2024

Capture-Free Deactivation of Circulating Tumor Cells in the Bloodstream Using Positive Electrostatic Charges: A Method for Metastasis Suppression (Biosensors and Bioelectronics) in Cancer Treatment

Leave a Comment / In Vivo, Research Articles /

Key Findings: Effectiveness Against Circulating Tumor Cells: The study demonstrated that PECs could effectively deactivate circulating tumor cells (CTCs) in the bloodstream. The efficacy of PECs was evaluated using both in vitro and in vivo models, including human metastatic breast cancer cell lines (MDA- MB-231) and mouse mammary carcinoma cell lines (4T1). CTC Deactivation: PECs treatment significantly reduced […]

Capture-Free Deactivation of Circulating Tumor Cells in the Bloodstream Using Positive Electrostatic Charges: A Method for Metastasis Suppression (Biosensors and Bioelectronics) in Cancer Treatment Read More »

Pilot Study on the Effects of Positive Electrostatic Charge as a Cancer Treatment for Late-Stage Metastatic Solid Tumors in Humans (Frontiers in Medicine)

Leave a Comment / Clinical, Research Articles /

Key Findings: Patient Demographics and Study Design: This human pilot study involved 41 patients with late-stage metastatic cancer, all with solid tumors that were unresponsive to conventional therapies such as chemotherapy and radiotherapy. These patients were considered for Positive Electrostatic Charge Therapy (PECT) as a last resort. Tumor Response: Significant Tumor Reduction: Over 80% of

Pilot Study on the Effects of Positive Electrostatic Charge as a Cancer Treatment for Late-Stage Metastatic Solid Tumors in Humans (Frontiers in Medicine) Read More »

12 Years of Coexisting with an Inoperable Brain Tumor Supported by ECCT

Leave a Comment / Brain Tumor, Meningioma /

In 2012, Mrs. Herin was diagnosed with a meningioma-type brain tumor located right behind her eyes, in the area between her right and left eyes, known as the sella and suprasella regions. Surgery couldn’t remove all of the tumor. It recurred, spreading throughout the suprasella area, gripping her optic nerves, and attaching to the brain stem, causing her vision problems. Worse, her doctor informed her that she might not survive more than six months.

A second surgery was not an option, and there were no other alternatives. She began using ECCT (Electro-Capacitive Cancer Therapy) at the end of 2012. The tumor stopped growing after using the ECCT device, but it wasn’t easy for Mrs. Herin to accept that her tumor could not be completely removed, her vision couldn’t fully return, and she had to come to terms with relying solely on her left eye for sight. After ten years, the tumor appears unchanged.

Mrs. Herin continues using the ECCT device. Despite her vision problems, she remains healthy and active.

12 Years of Coexisting with an Inoperable Brain Tumor Supported by ECCT Read More »